减少孔道机器人远端胃切除术治疗胃癌的安全性与可行性:I/II期临床试验
这项单臂前瞻性I/II期试验纳入19例早期胃癌患者,由单一术者行减少孔道机器人远端胃切除术(RRDG),主要终点为30天并发症与死亡率。结果显示无中转开腹或腹腔镜事件,无重大并发症(0.0% [80% CI 0.0-11.4%]),中位手术时间190分钟、出血20 mL、清扫淋巴结48枚、排气3天、住院5天。结论认为RRDG安全可行,可作为早期胃癌传统机器人远端胃切除术的替代选择。
要点
- RRDG在早期胃癌中安全可行,无重大并发症(0.0% [80% CI 0.0-11.4%])。
- 中位手术时间190分钟、出血20 mL、清扫淋巴结48枚。
- 中位排气时间3天、住院5天,未发生中转手术事件。
核心结论
- RRDG经本试验判定安全可行,可作为早期胃癌传统机器人远端胃切除术的有效替代方案。
主要发现
- 无术中事件需中转腹腔镜或开腹手术,RRDG后未观察到重大并发症(0.0% [80% CI 0.0-11.4%])。
- 中位手术时间190分钟,中位出血量20 mL,中位清扫淋巴结数48枚。
- 中位排气时间3天,中位住院时间5天。
关键数值与推荐
- 主要终点为30天并发症与死亡率,结果为0.0% [80% CI 0.0-11.4%]。
临床怎么用
- 对早期胃癌可考虑采用减少孔道机器人远端胃切除术,但需由经验丰富的术者实施。
- 该术式使用Single-Site系统联合第三臂机器人,可能适用于其他实体器官疾病的微创手术。
局限性
- 单臂、单术者、样本量小(19例),未设对照组,结论需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Theoretically, reducing the number of ports required in minimally invasive surgery for gastric cancer would further minimize trauma associated therewith. Advances in single-site surgery have afforded surgeons the ability to perform reduced-port distal gastrectomy via a robotic approach using the Single-Site™ system, eliminating restrictions on the movement of surgical instruments. METHODS: This phase I/II study was designed as a single-arm prospective trial of reduced-port robotic distal gastrectomy (RRDG) by a single surgeon (NCT02347956). From January to October 2015, 40 individuals scheduled to undergo robotic surgery for early gastric cancer were asked to participate in the trial. Nineteen were enrolled and underwent RRDG. The primary endpoints were 30-day morbidity and mortality. RESULTS: No intraoperative event requiring conversion to laparoscopic or open surgery occurred, and no major complication was observed following RRDG (0.0% [80% CI (0.0-11.4%)]). Medians of operation time, blood loss, the number of retrieved lymph nodes, days until gas passing, and hospital stay were 190 min, 20 mL, 48, 3, and 5 days, respectively. CONCLUSIONS: Deemed safe and feasible through the present trial, RRDG could be a valid alternative to conventional robot distal gastrectomy for managing early gastric cancer. Our reduced-port robotic surgery using the Single-Site system and a third robotic arm could potentially be applicable as a highly advanced, minimally invasive surgery for other solid organ diseases.
引用
- Lee S, Kim JK, Kim YN, et al. Safety and feasibility of reduced-port robotic distal gastrectomy for gastric cancer: a phase I/II clinical trial. Surg Endosc. 2017. PMID: 28205030. doi:10.1007/s00464-017-5435-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。